Illumina Inc (ILMN) Dividend History

Company News

• Companion Diagnostic Markets Report 2025-2029: Diagnostic Firms Jockey for Position as Pharmaceutical Partnerships Flourish, Discover the Impact of AI

  The report examines the rapidly evolving companion diagnostics market, driven by advancements in artificial intelligence and the formation of innovative partnerships between diagnostic and pharmaceutical companies. It provides insights into market trends, growth opportunities, and the impact of emerging technologies across 18 countries and 4 regions.

  GlobeNewswire Inc.

  Featured Companies: A RPTX TEM TMO
• Forensic Genomics Market Research 2025 - Global Trends, Opportunity, and Forecasts 2020-2030 - Growing Integration of Artificial Intelligence and Machine Learning

  The forensic genomics market is expanding due to increased funding, heightened security concerns, and advanced forensic solutions demand. AI and machine learning enhance data analysis, improving investigative efficiency. However, data privacy and ethical concerns may hinder broader adoption.

  GlobeNewswire Inc.

  Featured Companies: A GEHC NEOG QGEN TMO
• Cell-Free DNA Isolation and Extraction Market - Global and Regional Analysis 2025-2035 | Research and Clinical Labs Boost Adoption of Cell-Free DNA Technologies

  The global cell-free DNA isolation and extraction market is growing due to rising cancer prevalence and government initiatives. Major players are investing in new products, leveraging techniques like PCR and NGS for applications in oncology and more.

  GlobeNewswire Inc.

  Featured Companies: A DHR PKI QGEN TMO
• miRNA Sequencing and Assays Market Research Report 2025-2030 with Focus on 25+ Major Players Such as Abcam, HTG Molecular Diagnostics, Illumina, Lexogen, Meridian Bioscience

  The miRNA Sequencing and Assays market is expected to grow from $379M in 2024 to $763.1M by 2030, driven by rising cancer prevalence, advancements in NGS technology, and growing demand for personalized medicine. Key players include Illumina and QIAGEN.

  GlobeNewswire Inc.

  Featured Companies: QGEN
• South East Asia Molecular Diagnostics Market Forecast to 2031: PCR Technology Leads Growth, Kits & Reagents Hold Largest Share

  The Southeast Asia molecular diagnostics market is expected to grow from $528.3 million in 2024 to $891.9 million by 2031, driven by an aging population, disease prevalence, and technological advancements. The market is segmented by offering, test type, technology, and application, with infectious diseases holding the largest share. Key players include Illumina, Thermo Fisher, and Roche.

  GlobeNewswire Inc.

  Featured Companies: TMO